Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 May 2021 | Story Linda Greyling
Matric achievers from across the country can now enter for the 40th Matriculant of the Year competition, hosted by the University of the Free State (UFS), Netwerk24, and Volksblad. From the left is Prof Francis Petersen, Rector and Vice-Chancellor of the UFS, Pieter Hoogenboezem, 2019 winner, and Gert Coetzee, Editor of Volksblad.

Pieter Hoogenboezem describes his first year as a student at the University of the Free State (UFS) as a roller-coaster ride. “I didn’t know what to expect, but I was also looking forward to it.”

The medical student and 39th winner of the Matriculant of the Year competition for 2019 says last year was an uphill struggle due to COVID-19, but when he was eventually able to return to campus in August, it was nice to experience a bit of student life. 

No one could have foreseen what would happen in the world in 2020. COVID-19 has changed everything and this popular annual competition, which has been presented ever since 1981, also had to be cancelled last year.

However, this could not get the better of a competition rooted so deeply in the school community, and matric learners from across the country can now enter for the 40th Matriculant of the Year competition hosted by the UFS, Netwerk24, and Volksblad.

Well-rounded matriculants – learners who not only excel academically, but who are also involved in culture, sport, and leadership at their schools – who intend to study full-time at the UFS in 2022 – can enter. Community service and community engagement are also taken into account during the judging process. Matriculants can enter themselves or they can be entered by their schools. However, the signature of the principal as well as the school’s stamp must appear on the form.

All entries are judged according to fixed criteria, and 25 semi-finalists are selected. A total of 14 finalists chosen from this 25 will take part in the Matriculant of the Year finals in Bloemfontein from 5 to 7 October. During the finals, interviews will be conducted with the finalists; they will participate in team sessions, after which the winner will be announced.

The winner and 13 finalists will receive prize money from the sponsors – Kovsie Alumni Trust, Mazars, Absa, and Pick n Pay Preller Walk, as well as bursaries from UFS Student Recruitment Services, the final gala event in Bloemfontein, and gifts to the value of R10 000. 

The other 11 semi-finalists will receive prize money from Kovsie Alumni Trust and bursaries from UFS Student Recruitment Services. 

Two special prizes of R5 000 each are sponsored by the Kovsie Alumni Trust and will be awarded for outstanding achievement in the field of leadership, academy, sport, or culture.

The bursaries and prize money will be paid as soon as the student has registered at the UFS. Entries must reach the UFS on or before 6 August 2021.

For entry forms or for more information, email Linda Greyling at greylinl@ufs.ac.za

News Archive

Champagne and cancer have more in common than you might think
2013-05-08

 

Photo: Supplied
08 May 2013

No, a glass of champagne will not cure cancer....

…But they have more in common than you might think.

Researchers from the Departments of Microbial Biochemical and Food Biotechnology, Physics and the Centre for Microscopy at the University of the Free State in South Africa were recently exploring the properties of yeast cells in wine and food to find out more of how yeast was able to manufacture the gas that caused bread to rise, champagne to fizz and traditional beer to foam. And the discovery they made is a breakthrough that may have enormous implications for the treatment of diseases in humans.

The team discovered that they could slice open cells with argon gas particles, and look inside. They were surprised to find a maze of tiny passages like gas chambers that allowed each cell to ‘breathe.’ It is this tiny set of ‘lungs’ that puts the bubbles in your bubbly and the bounce in your bread.

But it was the technique that the researchers used to open up the cells that caught the attention of the scientists at the Mayo Clinic (Tumor Angiogenesis and Vascular Biology Research Centre) in the US.

Using this technology, they ultimately aim to peer inside cells taken from a cancer patient to see how treatment was progressing. In this way they would be able to assist the Mayo team to target treatments more effectively, reduce dosages in order to make treatment gentler on the patient, and have an accurate view of how the cancer was being eliminated.

“Yes, we are working with the Mayo Clinic,” said Profes Lodewyk Kock from the Microbial, Biochemical and Food Biotechnology Department at the UFS.

“This technique we developed has enormous potential for cell research, whether it is for cancer treatment or any other investigation into the working of cells. Through nanotechnology, and our own invention called Auger-architectomics, we are able to see where no-one has been able to see before.”

The team of Prof Kock including Dr Chantel Swart, Kumisho Dithebe, Prof Hendrik Swart (Physics, UFS) and Prof Pieter van Wyk (Centre for Microscopy, UFS) unlocked the ‘missing link’ that explains the existence of bubbles inside yeasts, and incidentally have created a possible technique for tracking drug and chemotherapy treatment in human cells.

Their work has been published recently in FEMS Yeast Research, the leading international journal on yeast research. In addition, their discovery has been selected for display on the cover page of all 2013 issues of this journal.

One can most certainly raise a glass of champagne to celebrate that!

There are links for video lectures on the technique used and findings on the Internet at:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept